
Available for
patients OTC in 2 sizes
at national retailers
LUMIFY REDNESS RELIEVER EYE DROPS
LUMIFY (brimonidine tartrate ophthalmic solution 0.025%) is the first and only over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness due to minor eye irritations.
- - Fast-acting and long-lasting efficacy
- - A unique method of action for reducing redness†
- - Low risk for tachyphylaxis or rebound hyperemia when used as directed
- - Available for patients OTC in 2 sizes at national retailers
†LUMIFY is a selective α2-AR agonist that selectively constricts the venule while maintaining availability of oxygen to surrounding tissue.
SEE HOW LUMIFY WORKS DIFFERENTLY
LUMIFY selectively constricts the venule, alleviating the potential decrease of blood and oxygen flow to surrounding tissue.


HOW LUMIFY COMPARES

LUMIFY with low dose brimonidine tartrate
(Selective α2-AR agonist)

No tachyphylaxis and virtually no rebound redness in clinical trials when used as directed

LUMIFY selectively constricts the venule, alleviating the potential decrease of blood and oxygen flow to surrounding tissue


Other OTC redness relievers
(α1 or α1/α2-AR agonist)

Commonly associated with rebound redness and tachyphylaxis

Non-selective vasoconstrictors act on the arteriole, decreasing blood and oxygen flow to surrounding tissue








SEE THE RESULTS
Real results from real people, no retouching.*
Redness is reduced, and eyes look whiter and brighter.
After image taken 5 minutes post-instillation.
#1 EYE DOCTOR RECOMMENDED*
Hear what eye Care
Professionals
are saying
* IQVIA Q1 2023